Dr. Mark W. Vogel, MD
Urology (Urology Physician)
8635 W 3rd St, 1060w
Los Angeles, CA 90048
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 50
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 370
Licensed in California since 1979, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
CA license A33393 (first issued 1979; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cedars-Sinai Medical Center Los Angeles, CA
Medical groups
- Assuta Family Medical Group A Professional Medical Corporation (6 clinicians)
- New Century Institute for Urology and Andrology A.p.m.c. (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 370
- Services billed
- 2,147
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Manual urinalysis test with examination using microscope, automated | 499 | 237 |
| Ultrasound measurement of bladder capacity after voiding | 192 | 143 |
| Established patient office or other outpatient visit, 20-29 minutes | 189 | 121 |
| Established patient office or other outpatient visit, 30-39 minutes | 180 | 126 |
| Established patient office or other outpatient visit, 10-19 minutes | 179 | 93 |
| Established patient office or other outpatient visit, 40-54 minutes | 84 | 82 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 79 | 79 |
| Insertion of needle into vein for collection of blood sample | 58 | 46 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 52 | 37 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 49 | 38 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Los Angeles, CA | 402 |
| Finasteride Other prescribers in Los Angeles, CA | 335 |
| Oxybutynin Chloride Er (oxybutynin chloride) Other prescribers in Los Angeles, CA | 126 |
| Myrbetriq (mirabegron) Other prescribers in Los Angeles, CA | 125 |
| Alfuzosin Hcl Er (alfuzosin hcl) Other prescribers in Los Angeles, CA | 113 |
| Dutasteride Other prescribers in Los Angeles, CA | 37 |
| Silodosin Other prescribers in Los Angeles, CA | 33 |
| Gemtesa (vibegron) Other prescribers in Los Angeles, CA | 28 |
| Levofloxacin Other prescribers in Los Angeles, CA | 28 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Los Angeles, CA | 27 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 11 companies reported 18 payments worth $962 in total to this clinician.
| Janssen Biotech, Inc. | $311 |
|---|---|
| Procept Biorobotics Corporation | $228 |
| Baxter Healthcare | $150 |
| Urogen Pharma, Inc. | $60.07 |
| Dendreon Pharmaceuticals LLC | $52.24 |
| Telix Pharmaceuticals | $32.46 |
| Accord Healthcare, Inc. | $32.27 |
| AstraZeneca Pharmaceuticals LP | $28.06 |
| Food and Beverage | $962 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.